GSK to Produce 1 Billion Doses of Coronavirus Vaccine Booster in 2021
4 years, 7 months ago

GSK to Produce 1 Billion Doses of Coronavirus Vaccine Booster in 2021

News 18  

GlaxoSmithKline Plc will expand production of vaccine efficacy boosters, or adjuvants, to produce 1 billion doses in 2021 for use in shots for COVID-19, the British drugmaker said on Thursday. The London-listed company said it was in talks with governments on backing for the programme, which would effectively allow for a scaling up of production of future successful vaccines for the disease caused by the novel coronavirus. GSK’s adjuvant can reduce the amount of vaccine protein required per dose, which would allow for more vaccines to be made, the British drugmaker said. Experts have predicted that a successful vaccine will take over a year to develop, and companies and governments are pouring money into dozens of programmes as the only viable solution that will allow the world to escape durably from coronavirus lockdowns and get economies moving again.

British Vaccine Gsk  vaccines  booster  billion  successful  2021  allow  production  develop  produce  coronavirus  governments  doses  gsk  vaccine  drugmaker  british

History of this topic

GSK raises profit guidance as vaccine demand grows
8 months, 1 week ago

GSK raises profit guidance as vaccine demand grows

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. GSK said total sales grew by 10%, or 13% …

New COVID variant JN.1: Health Ministry says no need for booster dose
1 year ago

New COVID variant JN.1: Health Ministry says no need for booster dose

The Hindu  

Following the Union Health Ministry direction that States be alert and prepared for any possible surge in COVID-19 cases following the emergence of the new variant JN.1, senior health officials said that there is no move to recommend administration of vaccine booster dose for India. India saw a single-day rise of 656 COVID-1 infections while the active cases have increased …

U.S. FDA approves first RSV vaccine from GSK
1 year, 8 months ago

U.S. FDA approves first RSV vaccine from GSK

The Hindu  

The U.S. Food and Drug Administration has approved GSK Plc's respiratory syncytial virus vaccine, the British drugmaker said on May 3, making it the first shot to be cleared for protection against a common respiratory disease that can be fatal for older people. Analysts have estimated the market for RSV vaccines to surpass $10 billion by 2030. Credit Suisse analysts …

Can a new vaccine rollout change this beaten down pharma MNC's fortune in 2023?
1 year, 8 months ago

Can a new vaccine rollout change this beaten down pharma MNC's fortune in 2023?

Live Mint  

It's tough being a pharma company these days.the pharma sector, which once used to be the star of the street, has been witnessing bad times since 2022. Over the last few years, the company has underperformed relative to its peers due to a series of challenges, including oncology clinical failures and missing out on the lucrative market for the first …

U.S. authorizes updated COVID-19 boosters targeting newest variants
2 years, 4 months ago

U.S. authorizes updated COVID-19 boosters targeting newest variants

LA Times  

The U.S. on Wednesday authorized its first update to COVID-19 vaccines, booster doses that target today’s most common Omicron strains. “Give a clear, forward-looking set of expectations.” Here’s the rub: The original vaccines still offer strong protection against severe disease and death from COVID-19 for most generally healthy people, especially if they got that important first booster dose. First, FDA …

India needs vaccines that can quickly adapt to corona variants: VK Paul
3 years ago

India needs vaccines that can quickly adapt to corona variants: VK Paul

India Today  

Amid the Omicron threat, Niti Aayog member Dr VK Paul said on Tuesday that there is a potential scenario that our Covid-19 vaccines may become ineffective and India should have vaccine platforms that are 'adaptable quickly' with changing nature of the coronavirus variants. Addressing an event organised by industry body CII, the Covid Task Force chief called for modifying the …

No scientific evidence to support need for booster vaccine dose against COVID-19, says ICMR chief
3 years, 1 month ago

No scientific evidence to support need for booster vaccine dose against COVID-19, says ICMR chief

Firstpost  

According to sources, the booster dose issue is likely to be discussed in the next meeting of the National Technical Advisory Group on Immunisation in India New Delhi: There is no scientific evidence so far to support the need for a booster vaccine dose against COVID-19, ICMR director general Dr Balram Bhargava said on Monday underlining the completion of second …

No scientific evidence to support need for booster vaccine dose against COVID-19: ICMR chief
3 years, 1 month ago

No scientific evidence to support need for booster vaccine dose against COVID-19: ICMR chief

The Hindu  

There is no scientific evidence so far to support the need for a booster vaccine dose against COVID-19, ICMR Director General Dr Balram Bhargava said on Monday, underlining the completion of second dose for India's adult population is the priority for the government for now. "Administering the second dose of COVID-19 vaccine to all adult population and ensuring that not …

Coronavirus updates | Moderna lowers forecast for 2021 COVID-19 vaccine deliveries
3 years, 2 months ago

Coronavirus updates | Moderna lowers forecast for 2021 COVID-19 vaccine deliveries

The Hindu  

With 12,885 people testing positive for coronavirus in a day, India's total tally of COVID-19 cases rose to 3,43,21,025, while the active cases were recorded at 1,48,579, according to the Union Health Ministry data updated on Thursday. Here are the latest updates : South Korea South Korea buys 30 million doses of Pfizer's COVID-19 vaccine for 2022 South Korea on …

100-crore Milestone Achieved Through Made-in-India Covid Vaccines: Dr VK Paul
3 years, 2 months ago

100-crore Milestone Achieved Through Made-in-India Covid Vaccines: Dr VK Paul

News 18  

As the total Covid-19 vaccine doses administered in India crossed the 100-crore milestone, Covid taskforce chief Dr VK Paul said on Thursday this was a remarkable feat and had been achieved through the vaccines manufactured in India. FOLLOW | Coronavirus LIVE Updates: India Scripts History, Tweets PM Modi on 100 Crore Vaccine Feat, Expresses Gratitude to Doctors, Nurses “Today, India …

Japanese drugmaker to launch first-ever plant-based COVID vaccine
3 years, 2 months ago

Japanese drugmaker to launch first-ever plant-based COVID vaccine

India TV News  

Japanese pharmaceutical group Mitsubishi Tanabe Pharma is planning to launch the first-ever plant-based Covid-19 vaccine in the world, which will likely to be of low-cost, easier to transport as well as store than the conventional jabs, the media reported. "As with seasonal flu, we don't expect demand to suddenly disappear and there is still much uncertainty regarding emerging variants," Toshifumi …

Coronavirus update: Latest Covid-19 vaccine and US reopening news
3 years, 3 months ago

Coronavirus update: Latest Covid-19 vaccine and US reopening news

CNN  

The current evidence on Covid-19 vaccines does not appear to support a need for booster shots in the general public right now, according to an international group of vaccine scientists, including some from the US Food and Drug Administration and the World Health Organization. The FDA and other public health agencies around the world continue to examine evidence on Covid-19 …

Four more Indian pharma firms expected to begin COVID vaccine production by Oct-Nov, says Union health minister
3 years, 5 months ago

Four more Indian pharma firms expected to begin COVID vaccine production by Oct-Nov, says Union health minister

Firstpost  

During the Question Hour in the Rajya Sabha, Mansukh Mandaviya said India has administered 47 crore doses of vaccine so far New Delhi: Union Health Minister Mansukh Mandaviya on Tuesday said in Parliament that four more Indian pharma firms are expected to start anti-coronavirus vaccine production by October-November that will accelerate the inoculation drive. During the Question Hour in the …

WHO asks vaccine makers to prioritize doses for poor countries over booster shots
3 years, 5 months ago

WHO asks vaccine makers to prioritize doses for poor countries over booster shots

LA Times  

WHO chief Tedros Adhanom Ghebreyesus says COVID-19 vaccine makers should send doses to poor countries instead of pushing for booster shots in rich ones. Last week, Pfizer said it would seek authorization for a third dose of its COVID-19 vaccine, saying a booster shot could dramatically boost immunity and perhaps help ward off worrisome variants. Pfizer’s Dr. Mikael Dolsten said …

Sanofi, GSK get nod for phase 3 trial of covid-19 vaccine in India
3 years, 6 months ago

Sanofi, GSK get nod for phase 3 trial of covid-19 vaccine in India

Live Mint  

French pharmaceutical Sanofi and its British partner GlaxoSmithKline on Thursday said they have received the approval of the drugs controller general of India to conduct part of the global phase-3 efficacy trial of their jointly developed covid-19 vaccine in India. We believe our covid-19 adjuvanted, recombinant vaccine can make a significant contribution to the ongoing fight against covid-19 and are …

Do we need Covid-19 vaccine booster shot? Here is what WHO chief scientist says
3 years, 6 months ago

Do we need Covid-19 vaccine booster shot? Here is what WHO chief scientist says

India Today  

Amid supply delays, safety concerns that have slowed vaccination campaigns and deadly variants, many countries are exploring the option to switch to separate Covid-19 vaccines for second doses or booster shots. World Health Organisation's chief scientist Soumya Swaminathan has said there is not enough information to either confirm or dismiss the requirement for a booster shot after vaccination against Covid-19. …

G7 provides 1 billion COVID vaccine doses, will work to give more: Communique
3 years, 6 months ago

G7 provides 1 billion COVID vaccine doses, will work to give more: Communique

Live Mint  

CARBIS BAY, England: Group of Seven countries will provide 1 billion COVID-19 vaccine doses over the next year and work with the private sector, the G20 and other countries to increase the contribution over months to come, according to an almost finalised draft of the communique. "The commitments since we last met in February 2021 including here in Carbis Bay …

Centre targets cumulative procurement of 187 crore doses of Covid vaccines by year-end
3 years, 7 months ago

Centre targets cumulative procurement of 187 crore doses of Covid vaccines by year-end

India Today  

Addressing the nation on Monday, Prime Minister Narendra Modi said the central government will now procure 75 per cent of all Covid vaccines produced in the country. The government's target is to have cumulatively procured 187.2 crore doses by year-end. According to the roadmap, 53.6 crore doses of Covid vaccines will be made available till July 31. Orders placed for …

How India’s COVID Vaccine Rollout Fares Amid Global Shortage & Unequal Distribution
3 years, 7 months ago

How India’s COVID Vaccine Rollout Fares Amid Global Shortage & Unequal Distribution

News 18  

Analysts have noted that given the supply constraints, many wealthy countries are still standing in queue for vaccine doses despite their purchasing power. When it comes to the fully vaccinated population, India’s performance looks relatively weaker at just 3.3 per cent of the overall population, although it is still the highest among the large low- and lower- middle-income countries. Among …

India aims to procure around 25 cr Covid vaccine doses in two months: Report
3 years, 7 months ago

India aims to procure around 25 cr Covid vaccine doses in two months: Report

Live Mint  

Amid attempts to ramp up the Covid-19 vaccination drive in the country further, the Indian government on Sunday said that it targets to procure 20-25 crore coronavirus vaccine doses by July-end, and 30 crore doses in August-September, news agency ANI reported citing government sources. Pune-based Serum Institute of India will provide 10-12 crore doses of Covishield vaccine to Govt next …

Covid vaccines cannot be made available immediately, process takes time: Health Ministry
3 years, 7 months ago

Covid vaccines cannot be made available immediately, process takes time: Health Ministry

India Today  

Not all Covid-19 vaccines produced in India are immediately available for distribution, Lav Agarwal said on Monday. After completion of these tests, they are sent across the supply chain of India," said Lav Agarwal.. @MoHFW_INDIA JS Lav Agarwal on the question of gap between vaccine production and supply to states to @IndiaToday clarified produced vaccine doses are not immediately available …

May 17, 2021 coronavirus news
3 years, 7 months ago

May 17, 2021 coronavirus news

CNN  

Medical personnel at the Nairobi National Vaccine Depot checks on Kenya's first batch of Covid-19 vaccines on March 4. Tony Karumba/AFP/Getty Images Kenya will run out of Covid-19 vaccines “anytime between the end of May and the first week of June,” according to the chair of Kenya’s vaccine taskforce. The East African nation had received just over 1 million of …

Coronavirus updates | May 10, 2021
3 years, 8 months ago

Coronavirus updates | May 10, 2021

The Hindu  

Experts have warned that recurring waves of coronavirus infections are inevitable if existing practices such as expanding India's vaccination drive and following COVID protocol are not adhered to. vaccine doses India is the fastest country globally to administer 17 crore COVID-19 vaccine doses, the Union Health Ministry said on Monday, May 10, 2021. The ministry said 2,46,269 beneficiaries of the …

GGD’s to boost Covid vaccine capacity to 2 million by end of May
3 years, 8 months ago

GGD’s to boost Covid vaccine capacity to 2 million by end of May

NL Times  

The GGD health branches in the Netherlands are preparing to administer up to 2 million Covid-19 vaccines per week starting from the end of May, ANP reported. Earlier on Thursday, the network of acute care providers announced that sixty hospitals in the Netherlands will be set up to become Covid-19 vaccination sites by the end of May, capable of administering …

COVID-19 vaccine: Bharat Biotech to boost Covaxin production to 700 million doses per year
3 years, 8 months ago

COVID-19 vaccine: Bharat Biotech to boost Covaxin production to 700 million doses per year

Firstpost  

Hyderabad: Bharat Biotech on Tuesday said it has scaled up its COVID-19 vaccine Covaxin manufacturing capacity to 700 million doses per annum. “Bharat Biotech is able to expandCovaxin manufacturing capacity in a short timeline, mainly due to the availability of new specially designed BSL-3 facilities, first of its kind for manufacturing in India that have been repurposed and preexisting expertise …

US Plant Ruins 15 Million Johnson & Johnson Coronavirus Vaccine Doses, Says Report
3 years, 9 months ago

US Plant Ruins 15 Million Johnson & Johnson Coronavirus Vaccine Doses, Says Report

News 18  

About 15 million doses of the single-shot coronavirus vaccine made by Johnson & Johnson were ruined in a factory error in the United States, The New York Times reported — a blow to the company’s efforts to quickly boost production. When contacted by AFP, the pharmaceutical giant said it had identified a batch of doses at a plant in Baltimore …

India to focus on meeting domestic demand of Covid-19 vaccine, no expansion of exports for now
3 years, 9 months ago

India to focus on meeting domestic demand of Covid-19 vaccine, no expansion of exports for now

India TV News  

India will focus on meeting the domestic demand for coronavirus vaccines in view of a spike in COVID-19 infections in several states and it will not expand export of vaccines for next few months, people familiar with the development said on Wednesday. The total supplies include vaccine doses sent as grant assistance, under commercial contract and through COVAX, which is …

Johnson & Johnson: The race to manufacture Covid-19 vaccines at record speed
3 years, 10 months ago

Johnson & Johnson: The race to manufacture Covid-19 vaccines at record speed

CNN  

CNN — Before the pandemic, Anne Leonard’s friends and family had only a cursory interest in her two decades of work manufacturing pharmaceuticals. But as President Joe Biden said Tuesday, “it simply wasn’t coming fast enough.” Biden announced that drugmaker Merck will help manufacture the Johnson & Johnson vaccine – a decision made after it became clear that J&J would …

GSK, CureVac band together to develop vaccine that will target new COVID-19 mutations
3 years, 11 months ago

GSK, CureVac band together to develop vaccine that will target new COVID-19 mutations

Firstpost  

Drugmaker GlaxoSmithKline said Wednesday it will work with a German biopharmaceutical company to develop new vaccines targeting emerging variants of COVID-19 amid concerns that some mutations are making the virus harder to combat. “The increase in emerging variants with the potential to reduce the efficacy of first-generation COVID-19 vaccines requires acceleration of efforts to develop vaccines against new variants to …

Coronavirus updates | February 4, 2021
3 years, 11 months ago

Coronavirus updates | February 4, 2021

The Hindu  

Vaccine hesitancy in India is dropping significantly, according to a nation-wide survey, which found that the percentage of citizens willing to take the COVID-19 vaccine immediately has increased from 31% to 42% in a month. Here are the latest updates: Alternate dosing vaccine trial UK begins world-first alternate dosing COVID-19 vaccine trial Health chiefs in the UK on Thursday began …

The coronavirus vaccine divide: In maps and charts
3 years, 11 months ago

The coronavirus vaccine divide: In maps and charts

Al Jazeera  

So far, at least 107 million COVID-19 vaccine doses have been administered by 78 countries around the world according to Our World in Data, a non-profit online scientific publication based at the University of Oxford. COVAX global vaccine initiative COVAX, which is a global initiative led by Gavi, the Coalition for Epidemic Preparedness Innovations and the WHO, aims to provide …

Bharat Biotech to make malaria vaccine
3 years, 11 months ago

Bharat Biotech to make malaria vaccine

The Hindu  

Global pharma major GSK, non-profit health organisation PATH and Bharat Biotech have signed a product transfer agreement pertaining to malaria vaccine RTS,S/AS01. The agreement includes transfer of manufacturing of the RTS,S antigen part of the vaccine and grant of a licence on all rights pertaining to the RTS,S/AS01 malaria vaccine to Bharat Biotech. A joint release on Wednesday said GSK …

India's pre-produced Covid vaccines in 6-month race against expiry
3 years, 11 months ago

India's pre-produced Covid vaccines in 6-month race against expiry

India Today  

The pre-produced Covid-19 vaccines in India need to be administered before they cross their six-month expiry date — a challenging task considering the number of Indian citizens who need to be vaccinated against Covid-19. Both the Covid-19 vaccines — Serum-Oxford-AstraZeneca's Covishield and Bharat Biotech's Covaxin — that are being administered as part of the country’s extensive vaccination programme have an …

Johnson & Johnson vaccine: What happens next for single-dose Covid-19 vaccine
3 years, 11 months ago

Johnson & Johnson vaccine: What happens next for single-dose Covid-19 vaccine

CNN  

CNN — If all has gone well with its clinical trial, Johnson & Johnson’s Covid-19 vaccine will likely be the next one available in the United States. “If this vaccine proves to be safe and effective, it could have major implications for the vaccine rollout because J&J has committed to producing and deploying at least a billion doses of vaccine …

Covid-19 vaccine in India: Bharat Biotech aims at making 700 mn doses in 2021
4 years ago

Covid-19 vaccine in India: Bharat Biotech aims at making 700 mn doses in 2021

Live Mint  

Hyderabad-based drug firm Bharat Biotech, said on Monday that it is aiming to produce 700 million doses of its indigenously produced Covid-19 vaccine, Covaxin this year. The announcement came a day after the vaccine manufacturer received approval for "restricted" emergency use authorization use from Drugs Controller General of India. We are aiming to achieve 700 million doses capacity in four …

Coronavirus updates | January 3, 2021
4 years ago

Coronavirus updates | January 3, 2021

The Hindu  

India has approved two COVID-19 vaccines — Serum Institute of India's 'Covishield' and Bharat Biotech's 'Covaxin' — for emergency restricted use, regulatory body DCGI said on Sunday. Vaccine approved Covishield, Covaxin approved for emergency use India's drug regulatory body has approved the use of Oxford's COVID-19 vaccine 'Covishield' and Bharat Biotech's 'Covaxin' for restricted emergency use. "The Subject Expert Committee …

Coronavirus | Serum Institute of India’s COVID-19 vaccine Covishield gets approval from DCGI’s expert panel
4 years ago

Coronavirus | Serum Institute of India’s COVID-19 vaccine Covishield gets approval from DCGI’s expert panel

The Hindu  

Covishield, the vaccine candidate from Pune-based Serum Institute of India, was approved by a Subject Expert Committee of the Drug Controller General of India late on Friday. “Similar to that in the United Kingdom, we've approved the vaccine to be given in two doses 4-12 weeks apart.” Covishield, which is similar to the ‘Oxford vaccine’ developed by the Oxford University …

Coronavirus | U.S. angling to secure more of Pfizer’s COVID-19 vaccine
4 years ago

Coronavirus | U.S. angling to secure more of Pfizer’s COVID-19 vaccine

The Hindu  

U.S. officials say they’re actively negotiating for additional purchases of Pfizer’s coronavirus vaccine after passing up a chance to lock in a contract this summer since it was still unclear how well the shots would work. There was no immediate comment from the company, whose CEO Albert Bourla told CNN this week it is working very collaboratively with the government …

Covid-19 vaccines would be available in India soon: Prakash Javadekar
4 years ago

Covid-19 vaccines would be available in India soon: Prakash Javadekar

Live Mint  

The vaccine for the novel coronavirus will be soon available in India, Union Minister Prakash Javadekar today said while speaking at International Coronavirus Short Film Festival. I urge everyone to not let their guard down before anti bodies are created and second dose of the vaccine administered: Union Minister @Prakash Javadekar while speaking at International Coronavirus Short Film Festival," PIB …

Covid-19 vaccine update: US panel's nod to Pfizer; India says no compromise on regulatory norms for vaccine
4 years ago

Covid-19 vaccine update: US panel's nod to Pfizer; India says no compromise on regulatory norms for vaccine

India Today  

A US government advisory panel has recommended emergency approval for the Pfizer-BioNTech coronavirus vaccine, underlining that the shot's potential benefits outweigh its risks. In India, Union Health Minister Harsh Vardhan has said the coronavirus vaccine is expected to be available in the coming weeks and with stringent oversight, it is being ensured that there is no compromise on the scientific …

Coronavirus | India is biggest buyer of COVID-19 vaccines: research
4 years, 1 month ago

Coronavirus | India is biggest buyer of COVID-19 vaccines: research

The Hindu  

India is the largest buyer of COVID-19vaccines in the world with 1.6 billion doses, according to a global analysis, a number some scientists say could cover 800 million people, or 60% of its population, and will be enough to develop ‘herd immunity’. Coronavirus | Haryana Minister, who is part of COVID-19 vaccine trial, tests positive | He got only one …

Coronavirus | Serum Institute of India stocking emergency doses of COVID-19 vaccine
4 years, 1 month ago

Coronavirus | Serum Institute of India stocking emergency doses of COVID-19 vaccine

The Hindu  

The Pune-based vaccine manufacturer Serum Institute of India is expecting the results of the clinical trials of the COVID-19 vaccine candidate Covishield by January. “We have started manufacturing the product,” the SII’s Executive Director, Suresh Jadhav, said on Saturday, adding that the institute would produce 50 million to 60 million doses of the vaccine candidate developed by AstraZeneca and Oxford …

Bharat Biotech's coronavirus vaccine will be 60% effective, launch in Q2 of 2021, says top official
4 years, 1 month ago

Bharat Biotech's coronavirus vaccine will be 60% effective, launch in Q2 of 2021, says top official

India Today  

Bharat Biotech's 'Covaxin', a potential vaccine against the coronavirus infection, will be at least 60 per cent effective and the Indian biotechnology company is aiming to launch the coronavirus vaccine candidate in Q2 of 2021, confirmed a top official of the company. In an exclusive interview with India Today TV, Sai D Prasad, President, Quality Operations at Bharat Biotech, said …

India’s Covid-19 tally goes past 90 lakh-mark with 45,882 new cases in 24 hours
4 years, 1 month ago

India’s Covid-19 tally goes past 90 lakh-mark with 45,882 new cases in 24 hours

Live Mint  

India's coronavirus caseload surpassed the 90-lakh mark on Friday, data released by the Union health ministry showed. On Thursday, the country recorded 45,576 new coronavirus infections, taking India's overall Covid-19 case count since the outbreak at 89,58,484. Covid-19 vaccine update A 'safe and effective' Covid-19 vaccine will be available for general public in India by next year May or June, …

Coronavirus | Pfizer ends COVID-19 vaccine trial with 95% efficacy, to seek emergency-use authorisation
4 years, 1 month ago

Coronavirus | Pfizer ends COVID-19 vaccine trial with 95% efficacy, to seek emergency-use authorisation

The Hindu  

Pfizer Inc said on Wednesday that final results from the late-stage trial of its COVID-19 vaccine show it was 95% effective, adding it had the required two-months of safety data and would apply for emergency U.S. authorization within days. The drugmaker said efficacy of the vaccine developed with German partner BioNTech SE was consistent across age and ethnicity demographics, and …

Behind Pfizer's Covid-19 vaccine, an understated husband-and-wife 'dream team'
4 years, 2 months ago

Behind Pfizer's Covid-19 vaccine, an understated husband-and-wife 'dream team'

India Today  

Positive data on BioNTech and US partner Pfizer Inc's Covid-19 vaccine is an unlikely success for the married couple behind the German biotech firm, who have devoted their lives to harnessing the immune system against cancer. From humble roots as the son of a Turkish immigrant working at a Ford factory in Cologne, BioNTech Chief Executive Ugur Sahin, 55, now …

Coronavirus vaccine status: Pfizer’s vaccine could be ready by Christmas before Oxford-AstraZeneca’s
4 years, 2 months ago

Coronavirus vaccine status: Pfizer’s vaccine could be ready by Christmas before Oxford-AstraZeneca’s

Live Mint  

Top officials in the British government believe that a German coronavirus vaccine backed by Pfizer could be ready to distribute by Christmas before the results are in on AstraZeneca’s competing vaccine, with the first doses earmarked for the elderly and vulnerable, according to a report. “Senior government sources expect that a verdict on whether it works will be available before …

UK expert warns first set of COVID-19 vaccines likely to be 'imperfect'
4 years, 2 months ago

UK expert warns first set of COVID-19 vaccines likely to be 'imperfect'

India TV News  

The first set of COVID-19 vaccines that clear clinical trials for rollout to combat the deadly virus are likely to be imperfect and might not work equally for everyone, the chief of the UK government's Vaccine Taskforce has warned. Kate Bingham, Chair of the UK's Vaccine Taskforce set up earlier this year to coordinate global efforts in search of a …

COVID-19 vaccine may be available before Christmas
4 years, 2 months ago

COVID-19 vaccine may be available before Christmas

Live Mint  

A COVID-19 vaccine may be available for some people before Christmas, Kate Bingham, the chair of the UK government’s vaccine taskforce said in an interview. "The first phase III efficacy data from the leading vaccine candidates are due by the end of 2020, subject to accruing sufficient rates of infection within the clinical trial cohorts to show the vaccines' efficacy. …

GSK, Sanofi to make 20 crore doses available for COVID-19 vaccine alliance
4 years, 2 months ago

GSK, Sanofi to make 20 crore doses available for COVID-19 vaccine alliance

Live Mint  

French drugmaker Sanofi SA and Britain's GlaxoSmithKline plan to make 200 million doses of their COVID-19 vaccine candidate available to the vaccine allocation plan co-led by GAVI and the World Health Organization. The companies said on Wednesday they have signed a statement of intent with vaccine alliance GAVI, which is coordinating the global plan known as COVAX. COVAX aims to …

Discover Related